The ARTH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARTH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARTH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARTH Detailed Price Forecast - CNN Money||View ARTH Detailed Summary - Google Finance|
|View ARTH Detailed Summary - Yahoo! Finance||View ARTH Stock Research & Analysis - Zacks.com|
|View ARTH Trends & Analysis - Trade-Ideas||View ARTH Major Holders - Barrons|
|View ARTH Call Transcripts - NASDAQ||View ARTH Breaking News & Analysis - Seeking Alpha|
|View ARTH Annual Report - CompanySpotlight.com||View ARTH OTC Short Report - OTCShortReport.com|
|View ARTH Fundamentals - TradeKing||View ARTH SEC Filings - Bar Chart|
|View Historical Prices for ARTH - The WSJ||View Performance/Total Return for ARTH - Morningstar|
|View the Analyst Estimates for ARTH - MarketWatch||View the Earnings History for ARTH - CNBC|
|View the ARTH Earnings - StockMarketWatch||View ARTH Buy or Sell Recommendations - MacroAxis|
|View the ARTH Bullish Patterns - American Bulls||View ARTH Short Pain Metrics - ShortPainBot.com|
|View ARTH Stock Mentions - StockTwits||View ARTH Stock Mentions - PennyStockTweets|
|View ARTH Stock Mentions - Twitter||View ARTH Investment Forum News - Investor Hub|
|View ARTH Stock Mentions - Yahoo! Message Board||View ARTH Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARTH - SECform4.com||View Insider Transactions for ARTH - Insider Cow|
|View ARTH Major Holdings Summary - CNBC||View Insider Disclosure for ARTH - OTC Markets|
|View Insider Transactions for ARTH - Yahoo! Finance||View Institutional Holdings for ARTH - NASDAQ|
|View ARTH Stock Insight & Charts - FinViz.com||View ARTH Investment Charts - StockCharts.com|
|View ARTH Stock Overview & Charts - BarChart||View ARTH User Generated Charts - Trading View|
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
Posted on Thursday December 06, 2018
Arch Therapeutics, Inc. (ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, presented an update on its corporate milestones, plans and timetables at the LD Micro Main Event XI in Los Angeles, California. Chief Executive Officer, Terrence W. Norchi, MD provided the following summary.
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
Posted on Tuesday December 04, 2018
FRAMINGHAM, Mass., Dec. 04, 2018 -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,.
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
Posted on Wednesday November 28, 2018
Arch Therapeutics, Inc. (ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company has submitted the required documents for AC5™ Topical Hemostat (AC5)1 to its Notified Body as it seeks a CE mark, which is a next step on the path to commercialization in countries governed by the European Medical Devices Directive (MDD). This first such submission by Arch to a European regulatory body follows the recent submission of a 510(k) premarket notification to the US Food and Drug Administration. Receipt of a CE mark would allow AC5 to be commercialized for use on external wounds, and in particular, for controlling bleeding by mechanically sealing areas of leakage and managing wounds in skin.
Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main Event on Tuesday, December 4, 2018
Posted on Monday November 26, 2018
Arch Therapeutics, Inc. (ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the LD Micro Main Event XI. Chief Executive Officer, Terrence W. Norchi, MD will deliver a corporate presentation on Tuesday, December 4 at 12:00 PM Pacific Time in Track 1.